BRPI0911552B8 - métodos para determinar a presença de um analito de interesse, e de uma pluralidade de analitos de interesse diferentes, e, composição - Google Patents

métodos para determinar a presença de um analito de interesse, e de uma pluralidade de analitos de interesse diferentes, e, composição

Info

Publication number
BRPI0911552B8
BRPI0911552B8 BRPI0911552A BRPI0911552A BRPI0911552B8 BR PI0911552 B8 BRPI0911552 B8 BR PI0911552B8 BR PI0911552 A BRPI0911552 A BR PI0911552A BR PI0911552 A BRPI0911552 A BR PI0911552A BR PI0911552 B8 BRPI0911552 B8 BR PI0911552B8
Authority
BR
Brazil
Prior art keywords
interest
methods
analytes
analyte
determining
Prior art date
Application number
BRPI0911552A
Other languages
English (en)
Inventor
I Schaffer Michael
Atefi Mohammad
Hill Virginia
Original Assignee
Psychemedics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Psychemedics Corp filed Critical Psychemedics Corp
Publication of BRPI0911552A2 publication Critical patent/BRPI0911552A2/pt
Publication of BRPI0911552B1 publication Critical patent/BRPI0911552B1/pt
Publication of BRPI0911552B8 publication Critical patent/BRPI0911552B8/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948—Sedatives, e.g. cannabinoids, barbiturates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
    • G01N2474/20—Immunohistochemistry assay

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

métodos para determinar a presença de um analito de interesse, de uma pluralidade de analitos de interesse diferentes, e de pelo menos um membro de uma classe de drogas de interesse, composição, e, kit composições e métodos para detectar a presença e/ou quantidade de um ou mais analitos, incluindo analitos tais como drogas de abuso, são fornecidos. as composições incluem dois ou mais analitos associados com uma fase sólida, por exemplo, uma partícula ou uma placa de reservatório múltiplo. as composições e métodos também permitem a determinação simultânea, em tandem ou serial da presença e/ou quantidade de dois ou mais analitos de interesse em uma amostra.
BRPI0911552A 2008-04-29 2009-04-29 métodos para determinar a presença de um analito de interesse, e de uma pluralidade de analitos de interesse diferentes, e, composição BRPI0911552B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4889208P 2008-04-29 2008-04-29
US61/048892 2008-04-29
PCT/US2009/042061 WO2009134855A1 (en) 2008-04-29 2009-04-29 Solid phase multi-analyte assay

Publications (3)

Publication Number Publication Date
BRPI0911552A2 BRPI0911552A2 (pt) 2019-03-06
BRPI0911552B1 BRPI0911552B1 (pt) 2019-11-05
BRPI0911552B8 true BRPI0911552B8 (pt) 2021-07-27

Family

ID=40802062

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0911552A BRPI0911552B8 (pt) 2008-04-29 2009-04-29 métodos para determinar a presença de um analito de interesse, e de uma pluralidade de analitos de interesse diferentes, e, composição

Country Status (11)

Country Link
US (1) US10539580B2 (pt)
EP (2) EP2623987B1 (pt)
JP (2) JP5564491B2 (pt)
CN (2) CN102077094B (pt)
BR (1) BRPI0911552B8 (pt)
CA (2) CA2943923C (pt)
ES (2) ES2562659T3 (pt)
HK (3) HK1154072A1 (pt)
HU (1) HUE028235T2 (pt)
PL (2) PL2281204T3 (pt)
WO (1) WO2009134855A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5564491B2 (ja) 2008-04-29 2014-07-30 サイケメディクス コーポレイション 固相多分析物アッセイ法
CN102323414B (zh) * 2011-06-07 2013-09-11 西安金域医学检验所有限公司 一种***均相酶免疫检测试剂盒及其制备方法
BR112014032907A2 (pt) 2012-06-28 2017-06-27 Psychemedics Corp detecção de analitos em amostras de lavagem de cabelo
CN104736566A (zh) * 2012-08-21 2015-06-24 奥索临床诊断有限公司 帕潘立酮半抗原的抗体及其用途
US11340237B2 (en) * 2016-09-16 2022-05-24 Takeda Pharmaceutical Company Limited Metabolite biomarkers for diseases associated with the contact activation system
US10829810B2 (en) * 2016-09-30 2020-11-10 Gen-Probe Incorporated Compositions on plasma-treated surfaces

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US832917A (en) * 1906-02-26 1906-10-09 George A Macbeth Colored signal-lens.
US6022693A (en) 1987-12-28 2000-02-08 Psychemedics Corporation Hair analysis method
US6949344B1 (en) 1987-12-28 2005-09-27 Psychemical Corporation Hair analysis method
US5466579A (en) 1987-12-28 1995-11-14 Psychemedics Corporation Hair analysis method
US5324642A (en) 1987-12-28 1994-06-28 Psychemedics Corporation Ligand assays of enzymatic hair digests
US6582924B1 (en) 1987-12-28 2003-06-24 Psychemedics Corporation Hair analysis method
US4956467A (en) 1988-04-01 1990-09-11 American Cyanamid Company Nucleophilic tertiary organophosphines
JPH01276066A (ja) * 1988-04-28 1989-11-06 Mitsui Petrochem Ind Ltd 免疫検定法による低分子化合物の検出方法
JP2837921B2 (ja) 1990-05-22 1998-12-16 サイケメディクス コーポレイション 毛髪分析法
EP0467078B1 (en) 1990-07-18 1996-05-08 Abbott Laboratories An analyte-subtitute reagent for use in specific binding assay methods, devices and kits
US5712157A (en) 1994-12-20 1998-01-27 University Of Washington Methods and materials for the immunoassay of apolipoprotein(a) and lipoprotein(a)
DE19504198A1 (de) 1995-02-09 1996-08-14 Behringwerke Ag Kompetitiver Immuntest unter Verwendung komplexierter Analytderivate
US6329566B1 (en) * 1997-05-29 2001-12-11 The General Hospital Corporation Methods for the detection, treatment, and prevention of neurodegeneration
US6231982B1 (en) 1997-12-10 2001-05-15 Dade Behring Inc. Particle reagents having reduced matrix effects and containing an aldehyde-reactive functional group
AU2679899A (en) 1998-02-18 1999-09-06 Dade Behring Inc. Chemiluminescent compositions for use in detection of multiple analytes
JPH11248703A (ja) * 1998-03-04 1999-09-17 Sanyo Chem Ind Ltd 遊離ハプテンの免疫学的測定法
GB2339615B (en) * 1998-07-14 2001-02-07 Cozart Bioscience Ltd Screening device and method of screening an immunoassay test
US7297554B2 (en) 1998-11-18 2007-11-20 Microdiagnostics, Inc. Immunoassay system
JP4288750B2 (ja) * 1999-05-14 2009-07-01 日油株式会社 免疫学的測定方法
US6509196B1 (en) * 2000-01-04 2003-01-21 Response Biomedical Corp. Compensation for non-specific signals in quantitative immunoassays
EP2341349A1 (en) 2000-05-04 2011-07-06 Siemens Healthcare Diagnostics Products GmbH Methods for detection of multiple analytes
US7083925B2 (en) 2002-01-11 2006-08-01 Schnabel Robert D Method of parentage testing in North American bison, Bison bison and domestic cattle using microsatellite loci
US7399470B2 (en) * 2002-03-12 2008-07-15 Japan Science And Technology Agency Sandwich immunoassay kits for detecting ciguatoxin CTX3C
US7067258B2 (en) * 2002-04-30 2006-06-27 Merck & Co., Inc. Human papillomavirus multiplexed assay
US7195875B2 (en) * 2003-04-18 2007-03-27 Beckman Coulter, Inc. Oligonucleotide pairs for multiplexed binding assays
US20040241776A1 (en) 2003-05-22 2004-12-02 Agdia, Inc. Multiplex enzyme-linked immunosorbent assay for detecting multiple analytes
US7323346B2 (en) * 2003-08-14 2008-01-29 The General Hospital Corporation Screening for gestational disorders
US7413868B2 (en) * 2003-11-05 2008-08-19 Trellis Bioscience, Inc. Use of particulate labels in bioanalyte detection methods
CN1673745A (zh) * 2003-12-20 2005-09-28 苏冬梅 酶联免疫吸附elisa同步快速测定多项免疫指标的方法
CA2554713C (en) 2004-01-28 2011-11-01 Bamburgh Marrsh Llc Specimen sample collection device and test system
GB2404022B (en) * 2004-06-14 2005-08-10 Cozart Bioscience Ltd Competitive assays for the detection of methamphetamine group drugs
US20060166376A1 (en) 2005-01-21 2006-07-27 Craig Alan R Compositions for use as a signal generation component and methods of using same
US7629129B1 (en) 2005-04-26 2009-12-08 The United States Of America As Represented By The Secretary Of The Army Hair follicle bulb as a biodosimeter
WO2006124456A2 (en) * 2005-05-11 2006-11-23 Embrex, Inc. Competitive particle immunoassay methods utilizing fluorescence microscopy
WO2007121436A2 (en) * 2006-04-17 2007-10-25 Luminex Corporation Methods, particles, and kits for determining activity of a kinase
CN1885038B (zh) * 2006-07-11 2010-08-18 华南农业大学 一种检测克伦特罗酶联免疫试剂盒及其检测方法与检测前动物组织的制样方法
KR101457716B1 (ko) * 2006-11-01 2014-11-03 베크만 컬터, 인코포레이티드 친화도 분석을 위한 결합 표면
US8084215B2 (en) 2008-04-29 2011-12-27 Psychemedics Corporation Non-proteolytic method for the determination of analytes in keratinized structures
JP5564491B2 (ja) 2008-04-29 2014-07-30 サイケメディクス コーポレイション 固相多分析物アッセイ法

Also Published As

Publication number Publication date
CN105675892A (zh) 2016-06-15
PL2281204T3 (pl) 2014-06-30
HK1186522A1 (zh) 2014-03-14
HUE028235T2 (en) 2016-12-28
EP2623987A1 (en) 2013-08-07
CA2723162C (en) 2016-11-01
US10539580B2 (en) 2020-01-21
EP2281204B1 (en) 2014-01-08
JP5564491B2 (ja) 2014-07-30
PL2623987T3 (pl) 2016-07-29
HK1154072A1 (en) 2012-04-13
US20110118138A1 (en) 2011-05-19
EP2281204A1 (en) 2011-02-09
CA2723162A1 (en) 2009-11-05
BRPI0911552B1 (pt) 2019-11-05
ES2452473T3 (es) 2014-04-01
EP2623987B1 (en) 2015-12-30
HK1155221A1 (zh) 2012-05-11
CN102077094A (zh) 2011-05-25
CN102077094B (zh) 2016-03-09
ES2562659T3 (es) 2016-03-07
WO2009134855A1 (en) 2009-11-05
CA2943923C (en) 2018-02-06
BRPI0911552A2 (pt) 2019-03-06
JP2011519048A (ja) 2011-06-30
JP5890864B2 (ja) 2016-03-22
JP2014209123A (ja) 2014-11-06
CA2943923A1 (en) 2009-11-05

Similar Documents

Publication Publication Date Title
Brook et al. Synchronous deficits in cumulative muscle protein synthesis and ribosomal biogenesis underlie age‐related anabolic resistance to exercise in humans
BRPI0911552B8 (pt) métodos para determinar a presença de um analito de interesse, e de uma pluralidade de analitos de interesse diferentes, e, composição
Pannérec et al. Vitamin B12 deficiency and impaired expression of amnionless during aging
Terry et al. DNA methylation in white blood cells: association with risk factors in epidemiologic studies
Misiak et al. Effects of second-generation antipsychotics on selected markers of one-carbon metabolism and metabolic syndrome components in first-episode schizophrenia patients
BR112014015152A2 (pt) métodos e materiais para a avaliação da perda de heterozigosidade
BR112013002236A2 (pt) "substrato polimérico, métodos para fornecer um substrato polimérico, para fabricar um chip, e para analisar, detectar, separar e/ou transportar analitos, chip feito de dois substratos, kits para a fabricação de um chip e para a análise e/ou detecção e/ou separação e/ou transporte de analitos, e, uso de um substrato polimérico."
BRPI0516005A (pt) determinação de concentração em uma camada-barreira de difusão
Pizzolo et al. Folic acid effects on s-adenosylmethionine, s-adenosylhomocysteine, and DNA methylation in patients with intermediate hyperhomocysteinemia
Abad et al. Common Metabolic Pathways Implicated in Resistance to Chemotherapy Point to a Key Mitochondrial Role in Breast Cancer*[S]
BR112014019168A2 (pt) ensaio capaz de detectar de forma não degenerada presença ou ausência de analitos em um único volume de amostra, bem como método de detecção da presença ou ausência de analito dentre uma pluralidade dos mesmos
MX2010002113A (es) Metodos para detectar oligonucleotidos.
WO2009077864A3 (en) Compositions and methods of detecting tiabs
WO2012024255A3 (en) Camkk-beta as a target for treating cancer
WO2012019200A3 (en) Assay systems for determination of source contribution in a sample
GB2451042A (en) Reagents and methods for using human embryonic stem cells to evaluate toxicity of pharmaceutical compounds and other chemicals
WO2008011046A3 (en) Computer systems and methods for selecting subjects for clinical trials
Sprangers et al. How to determine kidney function in cancer patients?
Nammo et al. Genome-wide profiling of histone H3K27 acetylation featured fatty acid signalling in pancreatic beta cells in diet-induced obesity in mice
BR112014015603A8 (pt) métodos para sondagem de múltiplos alvos em uma amostra biológica e para análise da amostra biológica de multiplexação de alta produtividade, e, série de pelo menos duas imagens
WO2010051544A3 (en) Rapid homogeneous diagnostic testing platform based on lanthanide fluorescent resonance energy transfer
ES2530734T3 (es) Biomarcador en suero bioquímico
WO2013036754A3 (en) Methods and compositions for diagnosis of ovarian cancer
BRPI0820272A2 (pt) Métodos para determinar e para detectar um rearranjo cromossômico, para identificar um parceiro de rearranjo cromossômico, para diagnosticar uma doença em um indivíduo, para detectar uma translocação cromossômico equilibrada, para diagnosticar ou fornecer um prognóstico para um linfoma em um indivíduo, kit, arranjo
Ferraro et al. Tackling serum folate test in European countries within the health technology assessment paradigm: request appropriateness, assays and health outcomes

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 05/11/2019, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/04/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO